Megavac-6

Megavac-6
Product Description

Canine distemper (living), canine adeno virus (Living), canine parvo virus (living), canine adeno virus (inactivated) and leptospirosis vaccine, inactivated Freeze dried component Vial 1 coposition: Each single dose contains canine distemper virus (living ) B.P (Vet.) ≥ 10³ TCID50 [Propagated on vero cells], Canine adenovirus (living) B.P (Vet.)≥ 10³ TCID50 [propagate don MDCK cells],canine parvovirus (living) B.P (Vet.) ≥ 10³ TCID50 (≥ 128 HA units) [propagated on A72 cells]. maltose, gelatin and lactalbumin hydrolysate added as stabilizer. liquid component Vial 2 coposition: Each dose 1ml contains: inactivated canine adeno virus B.P (Vet.) [propagated on MDCK cells], inactiavted leptospira canicola B.P (Vet.) and inactivated leptospira icterohaemorrhagiae B.P (Vet.) adosrbed on to aluminium hydroxide gel, polymixin B.P as preservative 200IU, phosphate buffer as diluent q.s.

Read more Show less

Indian Immunologicals Ltd

  • IN
  • 2019
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator
View company profile
Categories
more categories Show less

Indian Immunologicals Ltd

  • IN
  • 2019
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator
View company profile

More Products from Indian Immunologicals Ltd (56)

  • Flunixin meglumin 50 mg /ml

    Product Flunixin meglumin 50 mg /ml

  • Foot and mouth disease concentrate bulk antigen serotype A- inactivated (for export purpose)

    Product Foot and mouth disease concentrate bulk antigen serotype A- inactivated (for export purpose)

    composition: FMD antigen serotype -A, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s
  • Foot and mouth disease concentrate bulk antigen serotype Asia-1 - inactivated (for export purpose)

    Product Foot and mouth disease concentrate bulk antigen serotype Asia-1 - inactivated (for export purpose)

    composition: FMD antigen serotype -A, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s
  • Foot and mouth disease concentrate bulk antigen serotype O- inactivated (for export purpose)

    Product Foot and mouth disease concentrate bulk antigen serotype O- inactivated (for export purpose)

    composition: FMD antigen serotype -O, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s
  • Ivermectin Bolus. 80mg

    Product Ivermectin Bolus. 80mg

    Ivermectin oral tablet is used to treat parasitic infections of your intestinal tract, skin, and eyes.
  • Ivermectin Tab. 10mg

    Product Ivermectin Tab. 10mg

    Ivermectin oral tablet is used to treat parasitic infections of your intestinal tract, skin, and eyes.
  • Megavac-7

    Product Megavac-7

    Freeze dried component vial 1: Each single dose contains: canine distemper virus (living) B.P (Vet.) ≥ 103 TCID 50 [propagated on vero cells]; canine adeno virus (living) B.P (Vet.) ≥ 103 TCID 50 [propagated on MDCK cells]; canine parvo virus (living) B.P (Vet.) ≥ 103 TCID 50 (≥ 128HA units) [propagated on...
  • Megavac-P

    Product Megavac-P

    Megavac - P (Inact.) vaccine contains tissue culture adapted strain of canine parvovirus grown on A-72 cell cultures and inactivated with ß-propiolactone. Aluminium hydroxide gel is used as an adjuvant.
  • Megavac-Pinact

    Product Megavac-Pinact

    Canine parvo virus inactivated B.P (Vet.) Each dose (1mL) contains: inactivayted canine parvovirus antigen [propagated on A72 cells]adsorbed on to aluminium hydroxide gel, polymixin B.P as preservative 200 IU phosphate buffer diluent q.s to 1mL
  • Nimesulide Bolus 1000mg

    Product Nimesulide Bolus 1000mg

  • Nimesulide inj. 100 mg/ml

    Product Nimesulide inj. 100 mg/ml

    Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) that has antipyretic and analgesic properties. The anti-inflammatory, analgesic and antipyretic activities of nimesulide.
  • NSP (non -structural protein) free FMD vaccine inactivated

    Product NSP (non -structural protein) free FMD vaccine inactivated

    NSP (non -structural protein) free FMD vaccine inactivated; composition: Each dose contains: trivalent NSP free FMD inactivated antigens of O, A and ais-1 strains adsorbed on to aluminium hyddroxide gel, mineral oil, saponion added as adjuvant, thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer ...
show all 56 other products

Indian Immunologicals Ltd resources (2)

  • COVID-19 VACCINE DEVELOPMENT

    News COVID-19 VACCINE DEVELOPMENT

    Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

    Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.
    8 May 2020
  • IIL Corporate Brochure

    Brochure IIL Corporate Brochure